{"id":"bendazol","rwe":[],"tags":[{"label":"bendazol","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Hypertensive disorder","category":"indication"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"dibazol","offLabel":[],"synonyms":["dibazol","bendazol"],"timeline":[],"brandName":"Dibazol","ecosystem":[{"indication":"Hypertensive disorder","otherDrugs":[{"name":"acebutolol","slug":"acebutolol","company":"Promius Pharma"},{"name":"aliskiren","slug":"aliskiren","company":"Novartis"},{"name":"amiloride","slug":"amiloride","company":"Paddock Llc"},{"name":"amlodipine","slug":"amlodipine","company":"Pfizer"}],"globalPrevalence":null}],"mechanism":{"modality":"Small Molecule","drugClass":"bendazol","explanation":"Unfortunately, the exact way Dibazol works is not well understood, but it is thought to affect the body's blood pressure regulation system. This may involve influencing the activity of certain cells or chemicals in the body that help control blood pressure. By doing so, Dibazol may help to lower blood pressure and alleviate symptoms of hypertensive disorders.","oneSentence":"Dibazol works by interacting with a specific biological target to produce a therapeutic effect.","technicalDetail":"The technical details of Dibazol's mechanism of action are not well-documented, but it is likely to involve interaction with a specific receptor or enzyme that plays a role in blood pressure regulation."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/304","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BENDAZOL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:55:47.757903","biosimilars":[],"competitors":[],"genericName":"bendazol","indications":{"approved":[{"name":"Hypertensive disorder","source":"DrugCentral","snomedId":38341003,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"26601THN1D","CHEBI":"CHEBI:134876","INN_ID":"1091","UMLSCUI":"C2698355","ChEMBL_ID":"CHEMBL355063","KEGG_DRUG":"D07504","PUBCHEM_CID":"12132"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":12,"therapeuticAreas":["Cardiovascular"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dibazol is a small molecule with the synonyms BENDAZOL and NSC-60020. Its exact mechanism and clinical uses are not specified in the provided information.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":false,"score":2}}